Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

被引：19

作者：

Brown, Jennifer R. ^{[1
,2
,3
]}

Walker, Sarah R. ^{[1
,2
,3
]}

Heppler, Lisa N. ^{[1
]}

Tyekucheva, Svitlana ^{[4
]}

Nelson, Erik A. ^{[1
,2
,3
]}

Klitgaard, Josephine ^{[1
]}

Nicolais, Maria ^{[1
]}

Kroll, Yasmin ^{[1
]}

Xiang, Michael ^{[1
]}

Yeh, Jennifer E. ^{[1
]}

Chaudhury, Mousumi ^{[1
]}

Giaccone, Zachary T. ^{[1
]}

Fernandes, Stacey M. ^{[1
]}

Jacobsen, Eric D. ^{[1
,2
,3
]}

Fisher, David C. ^{[1
,2
,3
]}

Freedman, Arnold S. ^{[1
,2
,3
]}

Davids, Matthew S. ^{[1
,2
,3
]}

Supko, Jeffrey G. ^{[5
]}

Wu, Catherine ^{[1
,2
,3
]}

Frank, David A. ^{[1
,2
,3
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,Mayer 522B, Boston, MA 02215 USA

[2] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA

[3] Harvard Med Sch, Dept Med, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA

[5] Harvard Med Sch, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 04期

关键词：

TRANSCRIPTION;

D O I：

10.1002/ajh.26084

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E95 / E98

页数：4

共 50 条

[1] A Clinical Trial of the STAT3 Inhibitor Pyrimethamine in Chronic Lymphocytic Leukemia
Brown, Jennifer R.
Walker, Sarah R.
Heppler, Lisa N.
Tyekucheva, Svitlana
Nelson, Erik
Klitgaard, Josephine L.
Nicolais, Maria
Kroll, Yasmin
Xiang, Michael
Yeh, Jennifer E.
Chaudhury, Mousumi
Giaccone, Zachary T.
Fernandes, Stacey
Supko, Jeffrey G.
Wu, Catherine J.
Frank, David A.
BLOOD, 2018, 132
[2] Targeting the STAT3 pathway with STAT3 degraders
Wang, Zhijie
Liao, Xiaotong
He, Haiqi
Guo, Xia
Chen, Jianjun
TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (09) : 811 - 823
[3] At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells
Rozovski, Uri
Harris, David M.
Li, Ping
Liu, Zhiming
Wu, Ji Yuan
Grgurevic, Srdana
Faderl, Stefan
Ferrajoli, Alessandra
Wierda, William G.
Martinez, Matthew
Verstovsek, Srdan
Keating, Michael J.
Estrov, Zeev
JOURNAL OF IMMUNOLOGY, 2016, 196 (10): : 4400 - 4409
[4] Novel STAT3 inhibitors targeting the STAT3 dimerization
Hua, Yaping
Azeem, Waqas
Oyan, Anne Margrete
Kalland, Karl-Henning
CANCER RESEARCH, 2022, 82 (12)
[5] Generation and characterization of a constitutively active Stat3 protein
Barboza, JA
Wang, SG
Schaefer, TS
MOLECULAR BIOLOGY REPORTS, 2004, 31 (01) : 13 - 21
[6] Generation and characterization of a constitutively active Stat3 protein
Juan A. Barboza
Shuguang Wang
Timothy S. Schaefer
Molecular Biology Reports, 2004, 31 : 13 - 21
[7] Lymphocytes from patients with chronic lymphocytic leukemia contain STAT1 and STAT3 constitutively phosphorylated on serine.
Mahajan, S
Rudders, SA
Ritz, J
Frank, DA
BLOOD, 1996, 88 (10) : 1171 - 1171
[8] Constitutively Activated STAT3 Induces the Expression of Gli1 in Chronic Lymphocytic Leukemia Cells
Rozovski, Uri
Harris, David M.
Li, Ping
Liu, Zhiming
Manshouri, Taghi
Veletic, Ivo
Jain, Preetesh
Ferrajoli, Alessandra
Burger, Jan A.
Bose, Prithviraj
Thompson, Philip A.
Jain, Nitin
Verstovsek, Srdan
Wierda, William G.
Keating, Michael J.
Estrov, Zeev E.
BLOOD, 2019, 134
[9] Acute myeloid leukemia cells contain constitutively activated STAT3 and require STAT3 for survival.
Kim, TK
Carroll, M
Gewirtz, AM
BLOOD, 2004, 104 (11) : 919A - 920A
[10] STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells
Rozovski, Uri
Veletic, Ivo
Harris, David M.
Li, Ping
Liu, Zhiming
Jain, Preetesh
Manshouri, Taghi
Ferrajoli, Alessandra
Burger, Jan A.
Bose, Prithviraj
Thompson, Phillip A.
Jain, Nitin
Wierda, William G.
Verstovsek, Srdan
Keating, Michael J.
Estrov, Zeev
JOURNAL OF IMMUNOLOGY, 2022, 208 (12): : 2847 - 2855

← 1 2 3 4 5 →